Skip to main content
OpenTrials
Completed

NCT Number: NCT01037855

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

This is an observational study of safety and occurrence of influenza-like illness following administration of flu cell culture derived adjuvanted swine origin A (H1N1) pandemic subunit vaccine in subjects 6 months of age and older.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Novel Influenza A (H1N1) A New Flu Virus of Swine Origin

Age range

6 month and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinica Indisa, Av. Santa Maria, Santiago Metropolitan, Chile

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 6 months
  • Subjects will be vaccinated with Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine, independently of this study.
  • Subjects or parent/guardian willing to provide informed consent prior to vaccination administration and complete all of the study, including follow-up contact

Exclusion criteria

  • Received any prior H1N1 vaccination

Treatment and study plan

Non-intervention observational study

Other

Non-intervention observational study

Primary outcomes

  1. To quantify the safety of Flu Cell Culture Derived Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine in actively monitored subjects

    Time frame: 6 months

  2. To characterize the incidence of AEs in specific age groups following an active surveillance of vaccinated subjects

    Time frame: 6 months

Secondary outcomes

  1. To assess the occurrence of laboratory confirmed H1N1sw and influenza-like illness following vaccination

    Time frame: 6 Months

Sponsors and collaborators

Lead sponsor

Novartis Vaccines

Industry

Registry information

Official study title

A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Celtura

Important dates

Study start
2009
Primary completion
2010
Study completion
2011
First posted
Dec 23, 2009
Registry last updated
Mar 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.